Xiaojun Huang
Xiaojun Huang built the Beijing Protocol for stem cell transplants from half-matched family donors, which means almost every Chinese leukaemia patient can now find a donor.
Overview
Huang's group developed haploidentical transplantation without in vitro T-cell depletion using G-CSF-primed grafts and anti-thymocyte globulin (Bone Marrow Transplantation 2006), now the most common transplant type in China and increasingly used worldwide; his centre performs more haploidentical transplants than any other. Later work covers relapse prevention, GVHD and CAR-T bridging to transplant. Academician of the Chinese Academy of Engineering.
| Title | Journal | Year |
|---|---|---|
| Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies | Bone Marrow Transplantation | 2006 |
Pages like this
not linked directly; found by shared links- InstitutionInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tag china.
- ProductInaticabtagene autoleucel
Shares Acute lymphoblastic leukaemia and the tag china.
- PersonSaijuan Chen
Shares Acute myeloid leukaemia and the tag china.
- PersonZhu Chen
Shares Acute myeloid leukaemia and the tag china.
- CompanyOrca Bio
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- CompanyAllotera Therapeutics (formerly Wugen)
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- ProductBelumosudil
Shares Graft-versus-host disease (GVHD) and graft-versus-leukaemia, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- ProductDorocubicel (UM171-expanded cord blood)
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.